Should Low Molecular Weight PSMA Targeted Ligands Get Bigger and Use Albumin Ligands for PSMA Targeting?

por Huang, Steve S., Heston, Warren D.W.
Publicado 2017

GCP III is not the “off-target” for urea-based PSMA ligands

por Lee, Zhenghong, Heston, Warren D., Wang, Xinning, Basilion, James P.
Publicado 2023

Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression

por Yin, Lihong, Rao, Pravin, Elson, Paul, Wang, Jianghua, Ittmann, Michael, Heston, Warren D. W.
Publicado 2011

Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines

por Wang, Yu, Romigh, Todd, He, Xin, Orloff, Mohammed S., Silverman, Robert H., Heston, Warren D., Eng, Charis
Publicado 2010

PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells

por Chatterjee, Payel, Choudhary, Gaurav S., Sharma, Arishya, Singh, Kamini, Heston, Warren D., Ciezki, Jay, Klein, Eric A., Almasan, Alexandru
Publicado 2013

Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer

por Yang, Hanseul, Kim, Chan, Kim, Min-Ju, Schwendener, Reto A, Alitalo, Kari, Heston, Warren, Kim, Injune, Kim, Wun-Jae, Koh, Gou Young
Publicado 2011

Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin)

por Singh, Kamini, Sharma, Arishya, Mir, Maria C, Drazba, Judith A, Heston, Warren D, Magi-Galluzzi, Cristina, Hansel, Donna, Rubin, Brian P, Klein, Eric A, Almasan, Alexandru
Publicado 2014

CD117(+) cells in the circulation are predictive of advanced prostate cancer

por Kerr, Bethany A., Miocinovic, Ranko, Smith, Armine K., West, Xiaoxia Z., Watts, Katherine E., Alzayed, Amanda W., Klink, Joseph C., Mir, Maria C., Sturey, Tiffany, Hansel, Donna E., Heston, Warren D., Stephenson, Andrew J., Klein, Eric A., Byzova, Tatiana V.
Publicado 2014